- Colorimetric readout - 450 nm - Works on any standard plate reader
- Easy results interpretation
Reactivity data
Product details
Abcam's anti-Malaria Human in vitro ELISA (Enzyme-Linked Immunosorbent Assay) kit is designed for the accurate qualitative measurement of IgG and IgM class antibodies against Malaria in Human serum and plasma.
A 96-well plate has been precoated with Malaria antigens to bind cognate antibodies. Controls or test samples are added to the wells and incubated. Following washing, a horseradish peroxidase (HRP) labelled anti-Human IgG and anti-Human IgM conjugate is added to the wells, which binds to the immobilized Malaria antigens. TMB is then catalyzed by the HRP to produce a blue color product that changes to yellow after adding an acidic stop solution. The intensity of yellow coloration is directly proportional to the amount of Malaria IgG or Malaria IgM sample captured in plate.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Precision
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
These antibodies play an important role in the immune response neutralizing malaria parasites and inhibiting their replication. They form part of a larger immune system complex that activates other immune cells to destroy the infected host cells. Anti-malaria ELISA assays including the ELISA malaria kit often test for these antibodies to assess immune response in patients. Such assays help in determining prior exposure to malaria and can guide treatment efforts. The presence of these antibodies serves as evidence of the body's attempt to control or eliminate the parasite.
Pathways
A specific interaction between anti-malaria antibodies and the malaria parasite surface proteins disrupts key pathways necessary for the parasite's survival and replication. These proteins are part of invasive pathways including the erythrocyte invasion pathway involving proteins like AMA1 and MSP1. These antibodies interfere with these pathways aiding in the prevention of successful parasite invasion and maturation within host cells. The disruption of these pathways limits the malaria parasite's ability to multiply and spread thereby providing an important checkpoint in malaria pathogenesis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com